Top Markets
Coin of the day
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc.

RLMD
Classement en actions #13829
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company... Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Prix de l'action
$4.36
Capitalisation boursière
$457.32M
Changement (1 jour)
0.69%
Changement (1 an)
289.29%
Pays
US
Échange Relmada Therapeutics, Inc. (RLMD)

Catégorie

Historique des divisions d’actions pour Relmada Therapeutics, Inc. (RLMD)
L’action Relmada Therapeutics, Inc. (symbole : RLMD) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 31, 2026.
Une action RLMD achetée avant le Aug 31, 2026 équivaudrait aujourd’hui à 0 actions RLMD.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH